Skip to main content
logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.770
+0.540 (24.22%)
At close: Jun 26, 2026, 4:00 PM EDT
2.770
0.00 (0.00%)
After-hours: Jun 26, 2026, 7:58 PM EDT

Pyxis Oncology Revenue

Pyxis Oncology had revenue of $13.86M in the twelve months ending March 31, 2026. In the year 2025, Pyxis Oncology had annual revenue of $13.86M, down -14.17%.

Revenue (ttm)
$13.86M
Revenue Growth
-14.17%
P/S Ratio
12.66
Revenue / Employee
$247,464
Employees
56
Market Cap
175.49M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202513.86M-2.29M-14.17%
Dec 31, 202416.15M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Protalix BioTherapeutics76.38M
Precision BioSciences45.07M
LENZ Therapeutics20.99M
Caribou Biosciences11.20M
Innate Pharma10.57M
Korro Bio3.84M
Milestone Pharmaceuticals1.78M
YD Bio510.36K
Revenue Rankings

PYXS News

More News